These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10745480)
21. Reteplase infusion in the treatment of acute lower extremity occlusions. Kiproff PM; Yammine K; Potts JM; Nahum E J Thromb Thrombolysis; 2002 Apr; 13(2):75-9. PubMed ID: 12101383 [TBL] [Abstract][Full Text] [Related]
22. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
23. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital. Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822 [TBL] [Abstract][Full Text] [Related]
24. Isolated limb perfusion with tissue plasminogen activator for acute hand ischemia. Gilani R; Greenberg RK; Johnston DR J Vasc Surg; 2009 Sep; 50(3):659-62. PubMed ID: 19595553 [TBL] [Abstract][Full Text] [Related]
25. [Immediate reocclusion of the infrapopliteal segment after thrombolysis in acute ischemia of the lower limb of the thrombotic nature]. Belgrano EA; Nardella L; Palladino F Minerva Chir; 1995 Oct; 50(10):879-81. PubMed ID: 8684635 [TBL] [Abstract][Full Text] [Related]
27. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan. Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704 [TBL] [Abstract][Full Text] [Related]
28. Pharmacologic therapies in the treatment of peripheral vascular disease: clinical experience with reteplase, a third-generation thrombolytic. Laird JR J Invasive Cardiol; 2000 Mar; 12 Suppl B():27B-32B. PubMed ID: 10731297 [No Abstract] [Full Text] [Related]
36. Use and limitations of thrombolytic therapy in the treatment of peripheral arterial ischemia: results of a multi-institutional questionnaire. Ricotta JJ; Green RM; DeWeese JA J Vasc Surg; 1987 Jul; 6(1):45-50. PubMed ID: 3599280 [TBL] [Abstract][Full Text] [Related]
37. [Reteplase. A new thrombolytic agent in the treatment of acute myocardial infarction]. Jurlander B; Grande P Ugeskr Laeger; 1998 Jun; 160(24):3577-80. PubMed ID: 9641050 [No Abstract] [Full Text] [Related]
38. Hemodynamic and symptomatic improvement after delayed thrombolysis with Reteplase in a patient with massive bilateral pulmonary emboli. Sharif-Kashani B; Kiani A; Bakhshayesh-Karam M; Sheybani-Afshar F; Behzadnia N; Naghash-Zadeh F Blood Coagul Fibrinolysis; 2015 Jan; 26(1):88-90. PubMed ID: 24509336 [TBL] [Abstract][Full Text] [Related]